Latest Articles

Publication Date
The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.

This systematic review aimed to summarize the effects of astaxanthin (ASX) supplementation on oxidative stress, inflammation, and metabolic regulation in human studies. A systematic search was conducted in Scopus, Web …

Published: Jan. 9, 2026, midnight
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations - OncLive

Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations OncLive

Published: Jan. 2, 2026, 1:10 p.m.
Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Merigolix, a Nonpeptide Gonadotropin-Releasing Hormone Antagonist.

Gonadotropin-releasing hormone (GnRH) antagonists inhibit estrogen synthesis and secretion, making them promising treatment options for estrogen-dependent diseases, such as endometriosis. This study developed a population pharmacokinetic/pharmacodynamic (PK/PD) model for merigolix, …

Published: Dec. 20, 2025, midnight
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials - BiotechDispatch

Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials BiotechDispatch

Published: Dec. 1, 2025, 11:34 p.m.
Lack of Scientific Evidence for the Use of Gestrinone in the Treatment of Lipedema: A Systematic Review.

Lipedema is a chronic, progressive disorder marked by the abnormal accumulation of subcutaneous adipose tissue, predominantly in the lower body and almost exclusively affecting women. In recent years, the off-label …

Published: Nov. 19, 2025, midnight
S01 E07 - Why weren't women included in clinical trials? - TVO Today

S01 E07 - Why weren't women included in clinical trials? TVO Today

Published: Nov. 11, 2025, 2 p.m.
S01 E07 - Why weren't women included in clinical trials? - TVO

S01 E07 - Why weren't women included in clinical trials? TVO

Published: Nov. 11, 2025, 2 p.m.
Triple meeting 2025 – early efficacy signs for Quanta | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Triple meeting 2025 – early efficacy signs for Quanta | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Oct. 27, 2025, 3:49 p.m.
Digital Health Technologies in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review of Randomized Clinical Trials.

Objective: To comprehensively examine the qualitative results of current studies reporting the efficacy of digital health (DH) technologies in the treatment of chronic pelvic pain syndromes (CPPS) and to describe …

Published: Oct. 22, 2025, midnight
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - Clinical Trials Arena

ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability Clinical Trials Arena

Published: Oct. 20, 2025, 1:12 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!